- Advertisement -

Related

Nordic Cross in Multiple Hedge Fund Launch

- Advertisement -

Stockholm (HedgeNordic) – Nordic Cross Asset Management, a Swedish fund management company founded in 2016 by Caram (owned by the private equity company Altor) and a group of key people from Catella Fonder, is launching two new hedge funds and an additional one in the autumn of 2017, a press release states.

The new fund launches follow on an approval from the Swedish Financial Supervisory Authority where Nordic Cross Asset Management is given authority to manage alternative investment funds and discretionary investment portfolios.

The two initial launches, Nordic Cross Stable Return and Nordic Cross Total Return Bond Fund, had already gathered more than SEK 1 billion at inception on August 22. The third fund, Nordic Cross Small Cap Edge, will be launched in the autumn of 2017.

The funds will be managed by Ulf Strömsten, Mikael Hanell, Magnus Nilsson, Fredrik Tauson and Emil Nordström (pictured) who have a background from Catella and Carnegie.

All funds will be offered in UCITS format with daily dealing and a with a clear ESG profile, Ulf Strömsten, CIO of Nordic Cross Asset Management, says.

Short descriptions of the funds below.

Nordic Cross Stable Return

The fund is an actively managed alternative multi-strategy fund investing into fixed income instruments, equities and derivatives. The fund primarily invests in the Nordics and manages risk through the use of short positions and derivatives. The fund is managed by Ulf Strömsten, Mikael Hanell, Magnus Nilsson, Fredrik Tauson and Emil Nordström.

Nordic Cross Total Return Bond Fond

The fund is a Nordic-focused, actively managed, alternative fixed income fund. Investments are primarily done through investment grade bonds. Credit and interest rate risk is managed by using derivatives. The fund is managed by Fredrik Tauson, Magnus Nilsson and Emil Nordström.

Nordic Cross Small Cap Edge

The fund is an actively managed alternative equity fund with a focus on Nordic small-cap companies. The main strategy is equity long/short and the fund manages risk through the use of short positions and derivatives. The fund will be managed by Mikael Hanell, Ulf Strömsten och Emil Nordström.

 

Subscribe to HedgeBrev, HedgeNordic’s weekly newsletter, and never miss the latest news!

Our newsletter is sent once a week, every Friday.

Jonathan Furelid
Jonathan Furelid
Jonathan Furelid is editor and hedge fund analyst at HedgeNordic. Having a background allocating institutional portfolios of systematic strategies at CTA-specialist RPM Risk & Portfolio Management, Mr. Furelid’s focus areas include sytematic macro and CTAs. Jonathan can be reached at: jonathan@hedgenordic.com

Latest Articles

Systematic Multi-Strategy as a Portfolio Diversifier

By Fredrik Langenskiöld – Union Bancaire Privée: Multi-strategy funds are those that allocate to more than one alternative strategy or portfolio manager (PM) in...

Visio Allocator Delivers Record Month on AI Chip Rally

After a more muted, albeit still challenging, first quarter, multi-strategy fund Visio Allocator regained momentum starting in April and delivered its strongest month on...

Colosseum’s Difficult Stretch Continues as Co-Portfolio Manager Departs

After a volatile journey since launching in mid-2025, Colosseum Global Alpha has suffered two consecutive months of steep losses, leaving the fund down more...

CABA Offers Another Roll Down the Curve

CABA Capital has launched the fourth iteration of its Flex strategy, a three-year closed-ended AAA-yield premium strategy designed to harvest roll-down and pull-to-par effects...

Even Steven for Nordic CTAs in Mediocre May

May was another month characterized by reversals and cross-asset volatility. Strong momentum in U.S. equities contrasted with directionless moves across other markets, creating a...

Rhenman Doubles Down on Smaller Healthcare Innovators with New Fund

Many of healthcare’s most transformative breakthroughs often originate not from established industry giants, but from smaller companies developing new technologies, therapies, and treatment approaches....

Allocator Interviews

In-Depth: Diversification

- Advertisement -

Voices

Request for Proposal

- Advertisement -